Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-01

Study Completion Date

2041-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

NCT06120127

Radiotherapy Immunotherapy Liver Metastases +1 more

RECRUITING PHASE2

Prospective, Observational, Real-world Oral Malignant Tumors Study

NCT02395367

Head and Neck Neoplasms Quality of Life Postoperative Complications

COMPLETED

Supportive Clinic for Patients Living With Advanced and Metastatic Cancers

NCT06465511

Cancer Physical Symptom Distress

NOT_YET_RECRUITING NA

Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer

NCT03142282

Metastatic Colorectal Cancer Radiotherapy

UNKNOWN PHASE2

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

NCT03125161

Colorectal Adenocarcinoma Metastatic to the Liver

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-center continuous enrollment cohort study. The overall survival and disease-free survival of patients with malignant tumors in the target tumor hospital undergoing surgery, radiotherapy, chemotherapy, and immunotherapy were observed. Follow-up methods include medical records review, telephone call interview, and data linkage to the related provincial death certificate registries. This study will provide real world data-sets for researches on long-term survival and prognosis of cancer patients, and expend exploration on the cancer survival determinants both from clinical and social-economic prospective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms Survival Surgery Radiotherapy Drug Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All Cancers

subgroups according to cancer sites

hospitalization

Intervention Type PROCEDURE

Including various treatments such as surgery, radiotherapy, chemotherapy and immunotherapy during hospitalization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hospitalization

Including various treatments such as surgery, radiotherapy, chemotherapy and immunotherapy during hospitalization

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.